|
|
Volumn 18, Issue 9, 2001, Pages 1361-1366
|
|
Pharmaceutical significance of the cyclic imide form of recombinant human glial cell line derived neurotrophic factor
a
a
a
|
|
Author keywords
Cyclic imide; Protein stability; rhGDNF; Structure
|
|
Indexed keywords
8 ANILINO 1 NAPHTHALENESULFONIC ACID;
ASPARTIC ACID;
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
HEPARIN;
IMIDE;
RECOMBINANT HUMAN GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
RECOMBINANT NERVE GROWTH FACTOR;
UNCLASSIFIED DRUG;
AMINO ACID SEQUENCE;
ARTICLE;
BIOASSAY;
BIOEQUIVALENCE;
CHROMATOGRAPHY;
CIRCULAR DICHROISM;
DRUG ACTIVITY;
DRUG DEGRADATION;
DRUG FORMULATION;
DRUG QUALITY;
DRUG STABILITY;
DRUG STORAGE;
DRUG STRUCTURE;
HUMAN;
MASS SPECTROMETRY;
MELTING POINT;
PEPTIDE MAPPING;
PRIORITY JOURNAL;
PROTEIN PURIFICATION;
PROTEIN STABILITY;
STRUCTURE ANALYSIS;
ANIMALS;
ASPARTIC ACID;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CIRCULAR DICHROISM;
CYCLIZATION;
DROSOPHILA PROTEINS;
DRUG STABILITY;
DRUG STORAGE;
GANGLIA, SYMPATHETIC;
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR;
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS;
HEPARIN;
HUMANS;
HYDROGEN-ION CONCENTRATION;
IMIDES;
MICE;
MITOGENS;
NERVE GROWTH FACTORS;
NERVE TISSUE PROTEINS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-RET;
RATS;
RECEPTOR PROTEIN-TYROSINE KINASES;
RECOMBINANT PROTEINS;
SUBSTANTIA NIGRA;
|
|
EID: 0034842185
PISSN: 07248741
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1013058532425 Document Type: Article |
|
Times cited : (7)
|
|
References (15)
|
